drugset / Trial / NCT00480155

A Study to Evaluate the Safety of a Monovalent Vaccine in Healthy Adults

NCT00480155

Phase 2 Completed 300 enrolled MedImmune LLC
RandomizedSingle-groupDouble-blindTreatment

Summary

To assess the safety of a vaccine in healthy adults prior to the release of the vaccine (FluMist®) containing it.

Timeline

Start
2007-05
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator FluMist Vaccine 0.5 ml Intranasal

Indications

No indication recorded.